Regenerative Medicine, published by Taylor & Francis Ltd, is a pivotal journal within the field of biomedical research, focusing on the innovative advances in regenerative and restored functions in human health. With an ISSN of 1746-0751 and an E-ISSN of 1746-076X, this esteemed journal boasts a commendable impact factor within its categories, notably holding the Q2 status in Embryology and Q3 in Biomedical Engineering as of 2023. Covering a broad spectrum of topics from stem cell research to tissue engineering, it serves as a crucial platform for interdisciplinary collaboration among researchers, professionals, and students dedicated to the regeneration of tissues and organs. Given its comprehensive scope from 2006 to 2024, the journal continues to attract high-quality manuscripts that advance the frontiers of knowledge in regenerative medicine. Researchers and practitioners alike are encouraged to engage with the latest findings and methodologies disseminated in this vital publication.

JOURNAL OF MOLECULAR MEDICINE (JMM) is a premier publication dedicated to advancing the field of molecular medicine, encompassing critical areas such as drug discovery, genetics, and biochemistry. Published by Springer Heidelberg in Germany, this influential journal has established its significance within the academic community, achieving an impressive Q1 ranking across multiple categories as of 2023, including Drug Discovery, Clinical Genetics, and Molecular Medicine. With a focus on publishing high-quality research and novel insights, JMM appeals to a diverse audience of researchers, professionals, and students passionate about the molecular underpinnings of health and disease. The journal, which has seen a convergence of relevant research spanning from 1976 to 2024, is instrumental in showcasing groundbreaking studies that push the boundaries of knowledge in molecular therapeutics and biomedical science. While it does not offer open access, the rigor of its peer-reviewed content ensures that each publication is a valuable addition to the scientific discourse surrounding molecular medicine. For comprehensive studies and reviews that highlight the intersection of molecular biology and clinical application, look no further than JOURNAL OF MOLECULAR MEDICINE.

npj Regenerative Medicine, published by NATURE PORTFOLIO, is at the forefront of research and innovation in the field of regenerative medicine, fostering a deep understanding of cellular and molecular processes that can be leveraged for therapeutic advancements. Launched as an Open Access journal since 2016, it ensures wide dissemination of knowledge, allowing researchers, professionals, and students to access high-quality articles without barriers. With an impressive impact, it holds Q1 ratings across multiple categories including Biomedical Engineering, Cell Biology, Developmental Biology, and Medicine (miscellaneous) as of 2023, indicating its critical role in shaping contemporary scientific discourse. The journal ranks notably within the top 10% in multiple Scopus categories, indicating its commitment to publishing pioneering research that addresses pressing challenges in regenerative therapies. Addressing the dynamic convergence of disciplines, npj Regenerative Medicine is poised to not only impact academic thought but also translate into clinical applications, making it a pivotal resource for those invested in the future of medicine.

Photodiagnosis and Photodynamic Therapy is a leading journal published by Elsevier, specializing in the fields of biophysics, dermatology, oncology, and pharmacology. With an impressive Q2 ranking across multiple categories in the 2023 category quartiles, this journal is pivotal for researchers and practitioners aiming to advance their knowledge and expertise in photodiagnostic and therapeutic techniques. Since its inception in 2004, it has provided a critical platform for peer-reviewed articles exploring the latest advancements and applications in light-based treatments. As of 2024, the journal will be fully Open Access, enhancing its accessibility and reach across the scientific community. Located in Amsterdam, Netherlands, this journal's commitment to fostering innovation and collaboration makes it an essential resource for those interested in the intersection of light-based technologies and medicine. With its high visibility in key indexed databases like Scopus, researchers can trust that their contributions will be well-regarded and widely disseminated.

Regenerative Engineering and Translational Medicine is an esteemed academic journal published by Springer Heidelberg, focusing on the interdisciplinary fields of biomaterials, biomedical engineering, and cell biology. With an ISSN of 2364-4133 and an E-ISSN of 2364-4141, the journal has carved a niche for itself since its inception in 2015, showcasing cutting-edge research that bridges the gap between scientific findings and practical applications in regenerative medicine. As a recognized platform in its field, it is currently positioned within Q3 quartiles in biomaterials, biomedical engineering, and medicine (miscellaneous), with a Scopus ranking that reflects its growing influence among peers. The journal aims to disseminate high-quality, peer-reviewed articles that highlight advancements in regenerative engineering, further advancing both theoretical and applied research. Scholars and practitioners seeking to stay at the forefront of the ever-evolving landscape of regenerative health solutions will find invaluable insights and innovations within these pages. Join a community of leading thinkers and explore the journal's comprehensive research contributions, which are crucial for fostering partnerships between academia and industry in the quest for transformative medical solutions.

OPTICS AND LASERS IN ENGINEERING, published by Elsevier Science Ltd, is a premier journal dedicated to advancing the field of optics and laser technology in engineering applications. With a robust ISSN of 0143-8166 and E-ISSN 1873-0302, this journal is positioned within the top quartile (Q1) across several categories, including Atomic and Molecular Physics, Electrical Engineering, and Mechanical Engineering as of 2023, showcasing its prestige and impact in the scientific community. The journal has consistently ranked high in Scopus, notably within the top 10% for Mechanical Engineering and Electronic, Optical, and Magnetic Materials research. Since its inception in 1980, OPTICS AND LASERS IN ENGINEERING has served as a vital platform for disseminating cutting-edge research, fostering innovation and collaboration among researchers, professionals, and academia. Though it does not currently offer Open Access options, its high impact factor and selective publication process ensure that articles reach a wide audience while maintaining rigorous academic standards. Researchers and students alike are encouraged to engage with this influential journal to contribute to and stay abreast of advancements in optical technologies and their engineering applications.

LASERS IN MEDICAL SCIENCE is a prestigious journal published by Springer London Ltd, dedicated to advancing the field of medical laser applications. With an ISSN of 0268-8921 and an E-ISSN of 1435-604X, this journal serves as a vital platform for the dissemination of innovative research and clinical advancements in dermatology and surgery. Recognized within the 2023 Q2 category for both dermatology and surgery, it holds significant prominence, ranking amidst the top quartiles of the respective fields. The journal's Scopus rankings further emphasize its influence, with a percentile standing of 80th in medicine surgery and 75th in medicine dermatology. Although it does not offer open access, its content is essential for researchers, practitioners, and students seeking the latest insights and evidence-based practices in the science of lasers for medical applications, thus contributing to improved patient outcomes. Operating from its UK base at 236 Grays Inn Rd, 6th Floor, London WC1X 8HL, LASERS IN MEDICAL SCIENCE continues to push the frontiers of knowledge in laser medicine from its inception in 1986 through to 2024.

Nanomedicine-Nanotechnology Biology and Medicine is a leading journal published by Elsevier, dedicated to the exploration of innovative applications of nanotechnology in the fields of biology and medicine. With an ISSN of 1549-9634 and an E-ISSN of 1549-9642, this esteemed journal provides a platform for high-quality research, comprehensively covering areas including bioengineering, biomedical engineering, pharmaceutical science, and nanoscience. Notably, it holds a significant position in various categories with a Q2 ranking in multiple disciplines and a prestigious Q1 ranking in Pharmaceutical Science, emphasizing its impact within the scientific community. By facilitating access to cutting-edge studies and advancements, Nanomedicine-Nanotechnology Biology and Medicine serves as an essential resource for researchers, professionals, and students alike, contributing significantly to the ongoing development of nanomedicine and its pivotal role in improving healthcare outcomes. The journal operates without open access; however, it remains committed to disseminating valuable knowledge to a global audience.

Photochemistry and Photobiology is a premier journal published by Wiley, dedicated to advancing the field of photochemistry and its applications in biology. With a long-standing history since its inception in 1962, this journal is recognized for its significant contribution to the understanding of light-driven processes, encompassing areas such as biochemistry, medicine, and theoretical chemistry. As evidenced by its impressive Q2 rankings in several categories, including Biochemistry and Physical and Theoretical Chemistry, Photochemistry and Photobiology is an influential resource for researchers and professionals worldwide. The journal's commitment to high-quality research is reflected in its solid standing within important Scopus ranks, marking it as a vital outlet for innovative studies that elucidate the roles of photochemical reactions in biological systems. While it operates on a traditional model rather than Open Access, the journal remains a crucial platform for exchanging knowledge and fostering collaborations across these interconnected disciplines. Explore the latest findings and contribute to the growing body of knowledge in this dynamic field.

BioMedicine-Taiwan, published by DIGITAL COMMONS BEPRESS, stands as a prominent open-access journal that has been disseminating vital research since 2014. With an ISSN of 2211-8020 and E-ISSN 2211-8039, this journal covers a wide array of disciplines within the biomedical field, reaching researchers and professionals keen on exploring cutting-edge advancements and innovative approaches in biochemistry, genetics, and general medicine. Notably categorized as Q2 in Biochemistry, Genetics and Molecular Biology and Q3 in Medicine for 2023, BioMedicine-Taiwan ranks well in its respective fields, reflecting its commitment to enhancing scholarly communication and knowledge dissemination. Situated in Taiwan, its impact is further highlighted by its Scopus rankings—placing it in the 70th percentile for general medicine and 47th percentile for general biochemistry and molecular biology, showcasing its significance in ongoing biomedical discourse. Researchers, students, and professionals are invited to engage with this invaluable resource to explore the latest findings and developments that shape the future of healthcare and biological sciences.